Richmond, VA, United States of America

Erhard Bieberich

This inventor holds 1 USPTO granted patent. Top assignee: Virginia Commonwealth University. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erhard Bieberich. Retrieved from https://idiyas.com/inventor/erhard-bieberich-y81ul5bn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Erhard Bieberich: Innovator in Ceramide Analog Research

Introduction

Erhard Bieberich is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of biomedical research, particularly in the development of ceramide analogs for therapeutic applications. His work focuses on addressing disease conditions associated with abnormal cellular proliferation, inflammation, and viral infections.

Latest Patents

Bieberich holds a patent for "Hydroxyalkyl amide analogs of ceramide." This invention provides methods for treating various disease conditions by administering ceramide analogs. The analogs are designed to specifically modulate the enzyme PKC&zgr;, which plays a crucial role in cellular signaling pathways.

Career Highlights

Erhard Bieberich is affiliated with Virginia Commonwealth University, where he conducts research and contributes to the academic community. His innovative work has garnered attention in the scientific field, leading to advancements in therapeutic strategies for complex diseases.

Collaborations

Bieberich has collaborated with esteemed colleagues, including Raphael M Ottenbrite and Robert K Yu. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Erhard Bieberich's contributions to the field of ceramide analog research exemplify the importance of innovation in addressing critical health challenges. His work continues to inspire advancements in biomedical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…